White Paper: CHO Quasispecies – Implications for Manufacturing Processes Now Available The White Paper CHO Quasispecies – Implications for Manufacturing Processes is now freely available for viewing on our website. First published in Processes Journal in 2013, it has...
CHO Quasispecies – Implications for Manufacturing Processes AbstractChinese hamster ovary (CHO) cells are a source of multi-ton quantities of protein pharmaceuticals. They are, however, immortalized cells, characterized by a high degree of genetic and phenotypic...
Talks: Single-Use Bioreactors and Disposable Process Materials: How-To and Issues @ Disposable Solutions Berlin, Feb 19 Disposable materials in bioprocessing and single-use bioreactors have become widely used standards in R&D at small scale as well as cGMP based...
Cloning of CHO Cells, Productivity and Genetic Stability – a Discussion AbstractWhile many perceive mammalian cell culture-based manufacturing for biopharmaceuticals an established technology, numerous open questions remain to be solved. Genetic diversity and mutation...
Better media and feeds for higher CHO yield In an article written in November 2017 by Dr. Angelo DePalma in Genetic Engineering and Biotechnology News (GEN), ExcellGene and CSO Prof. F. Wurm were referred to discussing the benefits of better media and feeds as the...
